In this issue:
A non-D2-receptor-binding drug for the treatment of schizophrenia
Schizophrenia review article
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of multi-episode schizophrenia
Effects of age and sex on cognitive impairment in schizophrenia
A modelling approach to estimate the prevalence of TRS in the US
Association of ketamine with psychiatric symptoms and implications for its therapeutic use
Development and validation of a machine learning individualised treatment rule in first-episode schizophrenia
Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes
Efficacy and safety of aripiprazole lauroxil for acute schizophrenia transitioned to outpatient care
The trend of increasing placebo response and decreasing treatment effect in schizophrenia trials
Please login below to download this issue (PDF)